- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07419009
Muligheden for at modulere kognitiv kontrol ved OCD
Evaluering af Frontal Pole som et vindue til modulation af kognitiv kontrol ved OCD
This study tests out procedures to look at whether a type of brain stimulation called transcranial magnetic stimulation impacts flexible shifts in behavior in obsessive-compulsive disorder (OCD). This study examines whether study procedures are feasible and acceptable to people participating in the study, but does not determine whether this type of brain stimulation causes changes.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Current primary DSM-5 OCD diagnosis and current Y-BOCS total score of ≥16 (OCD group, only) or no current diagnosis of an emotional disorder, and no known history of OCD, PTSD, anxiety disorder(s), or recurrent major depressive disorder (Healthy participant group, only)
- 18-60 years of age
- ability to speak, read, write, and understand English sufficiently well to complete study procedures and provide informed consent
- psychotherapy and/or psychiatric medication use remain stable for 6 weeks prior to study entry
Exclusion Criteria:
- Presence of current psychiatric diagnosis (healthy control group, only)
- active substance use disorder
- history of mania or hypomania, or lifetime presence of significant psychotic symptoms
- active suicidal or homicidal ideation
- use of medications known to reduce seizure threshold (e.g., stimulants)
- organic brain disease or injury representing a contraindication to TMS
- any health problems that would interfere with safe and/or practical study participation, including contraindications to TMS (e.g., seizure disorder, presence of metal hardware that would come in close contact with the discharging coil)
- current pregnancy or planning to become pregnant during the study period
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: Obsessiv-kompulsiv lidelse (OCD)
|
3 consecutive daily sessions of cTBS |
|
Andet: Sunde Voksne Deltagere
|
3 consecutive daily sessions of cTBS |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of enrollment
Tidsramme: At study enrollment
|
Percent of screened participants who are determined to be eligible and enrolled. |
At study enrollment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Rates of visit completion
Tidsramme: From enrollment to date of post-TMS study visit (approximately 1 week)
|
Percent (%) of enrolled participants completing each study visit |
From enrollment to date of post-TMS study visit (approximately 1 week)
|
|
Peak cTBS intensity tolerated
Tidsramme: From enrollment to end of TMS sessions (approximately 1 week)
|
Average of peak intensity (up to target intensity) tolerated during cTBS sessions |
From enrollment to end of TMS sessions (approximately 1 week)
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- STUDY02003117
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .